ABBOTT LABORATORIES - COM (ABT)

Q1 2020 13F Holders as of 3/31/2020

Type / Class
Equity / COM
Number of holders
2110
Total shares
1.32B
Shares change
-5.49M
Total reported value, excl. options
$104B
Value change
-$487M
Put/Call ratio
0.85
Number of buys
918
Number of sells
-1035
Price
$78.91

Significant Holders of ABBOTT LABORATORIES - COM (ABT) as of Q1 2020

2,149 filings reported holding ABT - ABBOTT LABORATORIES - COM as of Q1 2020.
ABBOTT LABORATORIES - COM (ABT) has 2,110 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1.32B shares .
Largest 10 shareholders include VANGUARD GROUP INC (156M shares), BlackRock Inc. (128M shares), Capital Research Global Investors (95.9M shares), STATE STREET CORP (74.1M shares), Capital International Investors (55.8M shares), WELLINGTON MANAGEMENT GROUP LLP (43.2M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (27.4M shares), NORTHERN TRUST CORP (26.8M shares), BANK OF AMERICA CORP /DE/ (26.4M shares), and MORGAN STANLEY (25.4M shares).
This table shows the top 2110 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.